Inactive Instrument
Quest PharmaTech Inc Share Price Toronto S.E.
Stocks
QPT
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded
| Market Cap | 5.92M 4.18M 3.64M 3.37M 3.16M 394M 5.96M 40M 15.5M 194M 15.67M 15.34M 673M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 6.91M 4.87M 4.25M 3.93M 3.68M 460M 6.95M 46.66M 18.08M 226M 18.28M 17.89M 785M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 16/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 31/12/2004 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 16/06/2004 | |
J. Lievonen
CHM | Chairman | - | 04/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 04/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -15.38% | - | - | 4.18M | |
| +1.44% | +1.71% | -10.98% | -6.19% | 43.13B | |
| +3.31% | +5.93% | +310.97% | +534.70% | 34.65B | |
| +2.84% | +2.14% | +9.34% | +41.02% | 30.03B | |
| -1.70% | -7.54% | +8.43% | -21.94% | 28B | |
| -1.90% | -1.56% | +10.24% | +21.21% | 24.45B | |
| -0.14% | +5.86% | - | - | 14.34B | |
| +0.68% | -1.53% | +48.76% | +104.27% | 13.14B | |
| -0.57% | -2.43% | +5.08% | +4.79% | 12.53B | |
| -0.26% | +1.15% | +98.13% | +80.47% | 12.25B | |
| Average | +0.37% | +0.73% | +60.00% | +94.79% | 23.61B | |
| Weighted average by Cap. | +0.77% | +1.27% | +65.47% | +110.06% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.27M -1.11M -1.03M -960K -120M -1.81M -12.17M -4.72M -59M -4.77M -4.67M -205M | 5M 3.53M 3.07M 2.85M 2.67M 333M 5.03M 33.77M 13.09M 164M 13.23M 12.95M 569M |
| Net Debt | 795K 561K 489K 453K 424K 52.91M 800K 5.37M 2.08M 26.04M 2.1M 2.06M 90.42M | 986K 695K 606K 561K 526K 65.6M 992K 6.66M 2.58M 32.29M 2.61M 2.55M 112M |
Employees
-
